Patterns of allelic loss of synchronous adenocarcinomas of the lung
- PMID: 15958854
- DOI: 10.1097/01.pas.0000164367.96379.66
Patterns of allelic loss of synchronous adenocarcinomas of the lung
Abstract
Distinction of multiple primary lung carcinomas from intrapulmonary metastases using empiric clinical and histopathologic criteria can be difficult. Recent advances have provided several molecular markers that can be used for clonal analysis of separate tumor nodules and enhance tumor staging and subsequent treatment and prognosis. To address this issue, we performed a microdissection-based allelotyping of 20 cases of histologically similar, pathologic stage T4 adenocarcinomas (ADCs). Loss of heterozygosity (LOH) analysis included a panel of 15 polymorphic microsatellite markers located on 1p, 3p, 5q, 9p, 9q, 10q, 17p, and 22q. The tumor size, visceral pleural and angiolymphatic invasion, lymph node status, outcome, and survival were assessed. Allelotypes of 60 cases of solitary primary non-small cell lung carcinomas (NSCLC) (stages I-II) were used to define the percentage of discordant LOH patterns within solitary primary lung carcinoma that would discriminate between survivors and nonsurvivors. These criteria were used in the analysis of pathologic stage T4 ADC. Two groups of stage T4 cases were created: molecularly homogenous (< or = 40% discordances) (14 cases, 70%), and molecularly heterogenous (>40% discordances) (6 cases, 30%). Molecularly homogenous tumors were more frequently associated with visceral pleural invasion (92% vs. 8%) (P = 0.018). Allelotype did not correlate with age, gender, tumor size, tumor differentiation, lymph node status, angiolymphatic invasion, survival, or outcome. Our study showed that discordant and concordant genotypic profiles exist in morphologically similar synchronous ADC of the lung.
Similar articles
-
Clonal selection of adenocarcinoma of the lung as determined by loss of heterozygosity.Exp Mol Pathol. 2005 Apr;78(2):135-9. doi: 10.1016/j.yexmp.2004.10.002. Epub 2004 Dec 8. Exp Mol Pathol. 2005. PMID: 15713439
-
Comparison of accumulated allele loss between primary tumor and lymph node metastasis in stage II non-small cell lung carcinoma: implications for the timing of lymph node metastasis and prognostic value.Cancer Res. 2002 May 1;62(9):2681-9. Cancer Res. 2002. PMID: 11980668
-
[Distinguishing second primary tumors from lung metastasis in patients with postoperative non-small cell lung cancer by microsatellite analysis].Zhonghua Jie He He Hu Xi Za Zhi. 2007 Feb;30(2):103-7. Zhonghua Jie He He Hu Xi Za Zhi. 2007. PMID: 17445470 Chinese.
-
Loss of heterozygosity patterns of sclerosing hemangioma of the lung and bronchioloalveolar carcinoma indicate a similar molecular pathogenesis.Arch Pathol Lab Med. 2004 Aug;128(8):880-4. doi: 10.5858/2004-128-880-LOHPOS. Arch Pathol Lab Med. 2004. PMID: 15270615 Review.
-
Three different synchronous primary lung tumours: a case report with extensive genetic analysis and review of the literature.Lung Cancer. 2008 Mar;59(3):395-402. doi: 10.1016/j.lungcan.2007.07.007. Epub 2007 Aug 20. Lung Cancer. 2008. PMID: 17707945 Review.
Cited by
-
Total-genome analysis of BRCA1/2-related invasive carcinomas of the breast identifies tumor stroma as potential landscaper for neoplastic initiation.Am J Hum Genet. 2006 Jun;78(6):961-72. doi: 10.1086/504090. Epub 2006 Apr 12. Am J Hum Genet. 2006. PMID: 16685647 Free PMC article.
-
Restoration of fragile histidine triad expression restores Chk2 activity in response to ionizing radiation in oral squamous cell carcinoma cells.Cancer Sci. 2008 Mar;99(3):524-30. doi: 10.1111/j.1349-7006.2007.00707.x. Epub 2007 Dec 27. Cancer Sci. 2008. PMID: 18167129 Free PMC article.
-
Genomic and mutational profiling to assess clonal relationships between multiple non-small cell lung cancers.Clin Cancer Res. 2009 Aug 15;15(16):5184-90. doi: 10.1158/1078-0432.CCR-09-0594. Epub 2009 Aug 11. Clin Cancer Res. 2009. PMID: 19671847 Free PMC article.
-
Morphological and molecular approach to synchronous non-small cell lung carcinomas: impact on staging.Mod Pathol. 2016 Jul;29(7):735-42. doi: 10.1038/modpathol.2016.66. Epub 2016 Apr 15. Mod Pathol. 2016. PMID: 27080983
-
Histopathologic and molecular approach to staging of multiple lung nodules.Transl Lung Cancer Res. 2017 Oct;6(5):540-549. doi: 10.21037/tlcr.2017.06.11. Transl Lung Cancer Res. 2017. PMID: 29114470 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical